Virtu Financial LLC Cure Vac N.V. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$3.96 - $6.41 $148,939 - $241,086	37,611 New	37,611 $158,000
Q2 2023 Jul 27, 2023	BUY	$6.69 - $12.25 $71,235 - $130,438	10,648 New	10,648 $111,000
Q4 2021 Feb 17, 2022	SELL	$33.72 - $48.22 $350,688 - $501,488	-10,400 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$49.26 - $74.5 $505,506 - $764,519	-10,262 Reduced 49.67%	10,400 $568,000
Q2 2021 Sep 17, 2021	BUY	$56.91 - $127.53 $1.18 Million - $2.64 Million	20,662 New	20,662 $1.52 Million
Q1 2021 May 19, 2021	SELL	$79.79 - $126.29 $958,916 - $1.52 Million	-12,018 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$46.76 - $136.27 $561,961 - $1.64 Million	12,018 New	12,018 $974,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.